MIM
MetLife Investment Management Portfolio holdings
AUM
$17B
1-Year Return
25.61%
This Quarter Return
+24.56%
1 Year Return
+25.61%
3 Year Return
+108.53%
5 Year Return
+194.13%
10 Year Return
–
AUM
$8.79B
AUM Growth
+$1.45B
(+20%)
Cap. Flow
-$86.3M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
20.48%
Holding
2,422
New
180
Increased
1,163
Reduced
213
Closed
125
Top Buys
| 1 |
DexCom
DXCM
|
+$9.79M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$7.86M |
| 3 |
AbbVie
ABBV
|
+$7.83M |
| 4 |
T-Mobile US
TMUS
|
+$7.02M |
| 5 |
Otis Worldwide
OTIS
|
+$6.05M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$177M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$20M |
| 3 |
AGN
Allergan plc
AGN
|
+$15M |
| 4 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
+$14.7M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$10.6M |
Sector Composition
| 1 | Technology | 21.58% |
| 2 | Healthcare | 14.02% |
| 3 | Financials | 12.88% |
| 4 | Consumer Discretionary | 10.4% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Heritage Financial
HFWA
$850M
| $316K | ﹤0.01% |
15,777
| – | – |
|
1627
Cass Information Systems
CASS
$569M
| $316K | ﹤0.01% |
8,084
+2,194
| +37% | +$85.6K |
|
1628
CTS Corp
CTS
$1.24B
| $315K | ﹤0.01% |
15,701
| – | – |
|
1629
Progyny
PGNY
$1.96B
| $315K | ﹤0.01% |
12,187
+6,445
| +112% | +$166K |
|
1630
Cue Biopharma
CUE
$59.7M
| $314K | ﹤0.01% |
12,823
+2,817
| +28% | +$69K |
|
1631
Newmark Group
NMRK
$3.32B
| $313K | ﹤0.01% |
64,506
| – | – |
|
1632
Washington Trust Bancorp
WASH
$576M
| $313K | ﹤0.01% |
9,549
+2,563
| +37% | +$83.9K |
|
1633
Golar LNG
GLNG
$4.22B
| $312K | ﹤0.01% |
43,127
| – | – |
|
1634
Tronox
TROX
$755M
| $312K | ﹤0.01% |
43,198
| – | – |
|
|
TVRD
1635
Tvardi Therapeutics, Inc. Common Stock
TVRD
$278M
| $311K | ﹤0.01% |
506
| – | – |
|
1636
Wabash National
WNC
$463M
| $311K | ﹤0.01% |
29,260
+8,336
| +40% | +$88.5K |
|
1637
Kosmos Energy
KOS
$775M
| $310K | ﹤0.01% |
+186,480
| New | +$310K |
|
1638
OFG Bancorp
OFG
$1.97B
| $307K | ﹤0.01% |
22,996
| – | – |
|
1639
Center Bancorp
CNOB
$1.29B
| $307K | ﹤0.01% |
19,071
+5,211
| +38% | +$84K |
|
|
LBAI
1640
DELISTED
Lakeland Bancorp Inc
LBAI
| $307K | ﹤0.01% |
26,890
+6,957
| +35% | +$79.5K |
|
1641
Rocket Pharmaceuticals
RCKT
$346M
| $307K | ﹤0.01% |
14,674
| – | – |
|
1642
Unisys
UIS
$287M
| $306K | ﹤0.01% |
28,084
+7,342
| +35% | +$80.1K |
|
|
HSKA
1643
DELISTED
Heska Corp
HSKA
| $305K | ﹤0.01% |
3,277
| – | – |
|
1644
Acco Brands
ACCO
$364M
| $305K | ﹤0.01% |
42,900
| – | – |
|
1645
Assembly Biosciences
ASMB
$178M
| $304K | ﹤0.01% |
1,087
| – | – |
|
1646
Abercrombie & Fitch
ANF
$4.49B
| $303K | ﹤0.01% |
28,497
| – | – |
|
1647
CorVel
CRVL
$4.64B
| $302K | ﹤0.01% |
12,801
| – | – |
|
1648
Korro Bio
KRRO
$309M
| $302K | ﹤0.01% |
+260
| New | +$302K |
|
1649
Cohu
COHU
$959M
| $302K | ﹤0.01% |
17,431
| – | – |
|
1650
Relmada Therapeutics
RLMD
$51.8M
| $302K | ﹤0.01% |
+6,754
| New | +$302K |
|